Johnson & Johnson Vaccines May Be Compromised
The workers at Emergent BioSolutions’ Baltimore plant mixed up the ingredients for J&J’s single-dose vaccine and another COVID-19 inoculation being produced there several weeks ago based on the New York Times.
The error doesn’t affect J&J doses currently being delivered and used nationwide, as those were produced in the Netherlands, the report said.
However, it has caused ten of millions of doses that were going to come from the Baltimore factory — and were to be delivered within the next month — to be put into question, according to the Times.
The Food and Drug Administration in investigating the mixup, which federal officials have attributed to human error, the report said.
Meanwhile, J&J is said to be taking steps to tighten its control over Emergent BioSolutions’ work to avoid future lapses in quality. The biopharmaceutical company is a manufacturing partner of both J&J and AstraZeneca.
Federal officials still expect to have enough doses to meet President Biden’s goal of having enough vaccine for every US adult by the end of May.
The other two vaccines approved by the feds, from Pfizer and Moderna, are continuing to be delivered as expected.
Zhane Squire is Vision Newspaper’s dedicated Reggae Entertainment Correspondent, bringing readers the latest stories from Jamaica and across the global Afro-Caribbean diaspora. With a passion for music, culture, and storytelling, Squire highlights the voices, movements, and trends shaping reggae, dancehall, and Afro-Caribbean entertainment worldwide. His reporting connects Caribbean culture to the global stage, ensuring that artists, festivals, and community stories are told with depth, accuracy, and authenticity. For feedback you can reach him at zhane.squire@visionnewspaper.ca
